MGC Pharmaceuticals Ltd - pharmaceutical company specialising in plant-derived medicines - Calls general meeting for March 18 on resolution to change the company's name to Argent Biopharma Ltd. "The board proposes this change of name on the basis that it believes the proposed name more accurately reflects the future operations of the company," the firm says.
Current stock price: 20.00 pence, up 8.1% on late Tuesday morning in London
12-month change: down 97%
By Tom Budszus, Alliance News slot editor
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.